These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 12018784

  • 1. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
    Segreti AC, Leung HM, Koch GG, Davis RL, Mohberg NR, Peace KE.
    J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
    [Abstract] [Full Text] [Related]

  • 2. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT, Hagie F, Keen CL, Gershwin ME.
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [Abstract] [Full Text] [Related]

  • 3. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D, Tobbell DA.
    Bull Hist Med; 2011 Jan; 85(1):93-131. PubMed ID: 21551918
    [Abstract] [Full Text] [Related]

  • 4. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J.
    New Yorker; 2006 Dec 18; ():40-7. PubMed ID: 17176539
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM, Studdert DM, Brennan TA.
    N Engl J Med; 2009 Apr 09; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Food and Drug Administration: 100 years of protection.
    Mosocco DJ.
    Home Healthc Nurse; 2007 Mar 09; 25(3):148-50. PubMed ID: 17353704
    [No Abstract] [Full Text] [Related]

  • 12. Biopharmaceutical benchmarks--2003.
    Walsh G.
    Nat Biotechnol; 2003 Aug 09; 21(8):865-70. PubMed ID: 12894198
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA.
    Adv Cancer Res; 2007 Aug 09; 96():371-91. PubMed ID: 17161686
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacometrics at FDA: evolution and impact on decisions.
    Powell JR, Gobburu JV.
    Clin Pharmacol Ther; 2007 Jul 09; 82(1):97-102. PubMed ID: 17538553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A brief history of generic substitution in the USA.
    Sullivan CG.
    Pharm Pat Anal; 2012 Mar 09; 1(1):9-11. PubMed ID: 24236706
    [No Abstract] [Full Text] [Related]

  • 20. [Magic bullets, chemical gagging, controlled risks? On the research of the network "Pharmaceuticals in the 20th century" of the German Research Foundation (DFG)].
    Balz V, Bürgi M, Eschenbruch N, Hulverscheidt M.
    Medizinhist J; 2008 Mar 09; 43(2):183-201. PubMed ID: 18839933
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.